Trading Signals: LGND Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Ligand Pharmaceuticals Inc)
| LGND latest price $105.3400 (-0.72%) ($104.2600 - $105.3400) on Tue. Apr. 12, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.37% (three month average) | RSI | 47 | Latest Price | $105.3400(-0.72%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | LGND declines -1.2% a day on average for past five trading days. | Weekly Trend | LGND declines -2.8% a week on average for past two weeks. | Market Behavior | Normal for large cap. Normal for small cap. | Correlated ETFs | Broad market will support LGND advance at 0% a week (0% probability) IBB(60%) IWO(60%) IWM(58%) IWC(56%) IWN(56%) | Factors Impacting LGND price | LGND will decline at least -1.685% in a week (0% probabilities). VIXM(-24%) UUP(-20%) VXX(-16%) TBT(-8%) UNG(-5%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.685% (StdDev 3.37%) | Hourly BBV | -1.9 () | Intraday Trend | 0% | | | |
|
Resistance Level | $112.4 | 5 Day Moving Average | $109.04(-3.39%) | 10 Day Moving Average | $111.64(-5.64%) | 20 Day Moving Average | $112.4(-6.28%) | To recent high | -16.8% | To recent low | 10.5% | Market Cap | $1.693b | | | | Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and acquisition of technologies that help pharmaceutical companies to discover and develop medicines. Its products include evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV. The company was founded by Ronald M. Evans in 1987 and is headquartered in San Diego, CA. |